Submitted by Anonymous (not verified) on 19 August 2026 - 8:14
Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 35, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 35, Status: Authorised